New Frontiers in Metabolic Health: Updates on Diabetes, Obesity, Dyslipidemia and Cardiovascular Diseases

RATIONALE 

In recent years, the global prevalence of metabolic disorders such as diabetes, obesity, dyslipidemia, and associated cardiovascular diseases has reached unprecedented levels, contributing to substantial healthcare burdens and diminishing quality of life for millions worldwide. These interconnected conditions not only share pathophysiological mechanisms—including insulin resistance, chronic inflammation, and genetic predispositions—but also serve as major risk factors for cardiovascular morbidity and mortality, emphasizing the need for innovative, integrated therapeutic and preventive strategies. The symposium, "New Frontiers in Metabolic Health: Updates on Diabetes, Obesity, Dyslipidemia, and cardiovascular disease," seeks to convene leading experts, clinicians, and researchers to discuss the latest breakthroughs and challenges in managing and preventing these complex metabolic and cardiovascular disorders. Cardiovascular disease (CVD) is both a complication and a comorbidity of diabetes, obesity, and dyslipidemia, with shared underlying mechanisms that worsen patient outcomes. Advances in understanding how metabolic disturbances affect cardiovascular health are essential to inform risk assessment, early intervention, and personalized treatment approaches. Emerging pharmacotherapies, such as GLP-1 receptor agonists, SGLT2 inhibitors, and novel lipid-modifying agents, show potential not only for improving glycemic and lipid profiles but also for reducing cardiovascular risk, marking a significant shift toward therapies with dual metabolic and cardioprotective benefits. This congress will provide a platform for in-depth discussions on cutting-edge topics, including the implications of recent clinical trials, the use of digital health technologies for monitoring metabolic and cardiovascular health, and the role of lifestyle and nutritional interventions in risk reduction. By exploring these topics, we aim to foster a multidisciplinary dialogue that drives innovative solutions to reduce the incidence and impact of these pervasive diseases and improve patient outcomes holistically. In summary, "New Frontiers in Metabolic Health" will highlight the latest scientific insights and emerging treatments for diabetes, obesity, dyslipidemia, and cardiovascular disease. Attendees will have the opportunity to engage with novel research and discuss strategies for enhancing metabolic and cardiovascular health across diverse populations, with a focus on integrated, patient-centered care. 

SCIENTIFIC DIRECTORS